The BCW Index gained 1.2 percent for the week ended Tuesday, rising along with tech stocks in the Nasdaq and the Nasdaq Biotech Index. The Nasdaq rose 1.3 percent and the Nasdaq Biotech Index rose 1.7 percent for the tracking period, while the Dow Jones Industrial Average climbed .7 percent.
Stocks for 13 of the 16 companies in the Index gained ground for the week, led by Fisher Scientific, which rose 5.1 percent. Thermo Electron and Bruker Biosciences gained 4.7 percent and 4.4 percent, respectively.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.